{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"spastic-paraplegia-facial-cutaneous-lesions","columns":[{"gene":"","key":"population-8b38c3c3cceaa8ab2360","label":"Spastic paraplegia-facial-cutaneous lesions syndrome","mondoId":"MONDO:0017275","onsetQualifier":null,"originColumnKey":"MONDO:0017275/ORPHA:2819","originalViews":[{"key":"MONDO:0017275/ORPHA:2819","label":"Spastic paraplegia-facial-cutaneous lesions syndrome","scopeLabel":"ORPHA:2819","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["1f21cf3f95f9e62687fa1122a15b8de3cec4673e928bb99973e7421e1530765b","269fa10707737f7bd96fb328c87d72b34a8669db3b9e7d72e818f435879c02a1","422cd5d44d584306380858bd3e3a941b557c6e68b078c1cea60d16402c37ac4e","4d51b9d36cdbdb836513a080d306abc3820c476f06865714315b7fa2934c9e9d","5078b060b642b3e0ad4cbf75af6b1677bf4a4c34894818e7de10c3b4cd765c68","8543ad8cd479716c7fb8f5a503eaa983b54f627461b25fbd6c7b54c33d04d9d0","afa9cbca958f890bcfa8a35ba072d9aeaeac88b5a846ab39af88747ac1df3da0","c14bdd2577515fcbbf5ebf5db2753e7e947756b325f9d9b8af2d11eaf604fc77","fc0d0878e940ac212b6d9b8c27e82359e12b9bf92a03bcaad44f28aa8c1bde1f"],"recordQualifiers":{},"scopeLabel":"ORPHA:2819","sourceIds":["ORPHA:2819"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-8b38c3c3cceaa8ab2360"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002167","HP:0002353","HP:0001288","HP:0000953","HP:0001347","HP:0001053","HP:0010550"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":9,"sourceGroups":{"orphanet":9}},"features":[{"hpoId":"HP:0002167","label":"Abnormal speech pattern","primary":true},{"hpoId":"HP:0002353","label":"EEG abnormality","primary":true},{"hpoId":"HP:0001288","label":"Gait disturbance","primary":true},{"hpoId":"HP:0000953","label":"Hyperpigmentation of the skin","primary":true},{"hpoId":"HP:0001347","label":"Hyperreflexia","primary":true},{"hpoId":"HP:0001053","label":"Hypopigmented skin patches","primary":true},{"hpoId":"HP:0010550","label":"Paraplegia","primary":true},{"hpoId":"HP:0001257","label":"Spasticity","primary":false},{"hpoId":"HP:0001025","label":"Urticaria","primary":false}],"ledeHtml":"A complex form of hereditary spastic paraplegia characterized by delays in motor development followed by a slowly progressive spastic paraplegia (affecting mainly lower extremities) associated with a desquamating facial rash with butterfly distribution (presenting at around two months of age) and dysarthria. There have been no further descriptions in the literature since 1982.","mondoId":"MONDO:0017275","node":{"canonicalSlug":"spastic-paraplegia-facial-cutaneous-lesions","comparisons":[{"documentSha256":"b9b663ad128648f7b7269cff88b9a35266d94310d7eff7521d0dc590943fcebe","key":"legacy-autosomal-dominant-complex-spastic-paraplegia","kind":"legacy","label":"autosomal dominant complex spastic paraplegia","memberIds":["MONDO:0008440","MONDO:0008442","MONDO:0008443","MONDO:0011006","MONDO:0012334","MONDO:0012867","MONDO:0013132","MONDO:0015007","MONDO:0015087","MONDO:0017275","MONDO:0018005","MONDO:0018644"],"mondoId":"MONDO:0015087","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/autosomal-dominant-complex-spastic-paraplegia.b9b663ad128648f7b7269cff88b9a35266d94310d7eff7521d0dc590943fcebe.json"},{"documentSha256":"fafe28cd1cb1e2fd7861dcb5a98bf12183d4500ab9bbc38b492705afacc1f0c5","key":"expanded-autosomal-dominant-complex-spastic-paraplegia","kind":"expanded","label":"autosomal dominant complex spastic paraplegia","memberIds":["MONDO:0008439","MONDO:0008440","MONDO:0008442","MONDO:0008443","MONDO:0010043","MONDO:0011006","MONDO:0012334","MONDO:0012867","MONDO:0013132","MONDO:0015007","MONDO:0015087","MONDO:0015091","MONDO:0017275","MONDO:0018005","MONDO:0018644","MONDO:0957788"],"mondoId":"MONDO:0015087","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-fafe28cd1cb1e2fd7861.fafe28cd1cb1e2fd7861dcb5a98bf12183d4500ab9bbc38b492705afacc1f0c5.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Spastic paraplegia-facial-cutaneous lesions syndrome","originalSourceId":"ORPHA:2819","paragraphs":["A complex form of hereditary spastic paraplegia characterized by delays in motor development followed by a slowly progressive spastic paraplegia (affecting mainly lower extremities) associated with a desquamating facial rash with butterfly distribution (presenting at around two months of age) and dysarthria. There have been no further descriptions in the literature since 1982."],"rawAttribution":"MONDO:0017275","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:38:22Z","upstream":"MONDO:0017275","url":"https://rarediseases.info.nih.gov/diseases/806"},"ownColumnKeys":["population-8b38c3c3cceaa8ab2360"],"publication":"published","relationships":[{"kind":"parent","label":"autosomal dominant complex spastic paraplegia","mondoId":"MONDO:0015087","slug":"autosomal-dominant-complex-spastic-paraplegia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"1f21cf3f95f9e62687fa1122a15b8de3cec4673e928bb99973e7421e1530765b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2819","disease_name":"Spastic paraplegia-facial-cutaneous lesions syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002167","is_excluded":false,"label":"Abnormal speech pattern","onset_id":null,"reference":"ORPHA:2819","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"269fa10707737f7bd96fb328c87d72b34a8669db3b9e7d72e818f435879c02a1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2819","disease_name":"Spastic paraplegia-facial-cutaneous lesions syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"ORPHA:2819","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"422cd5d44d584306380858bd3e3a941b557c6e68b078c1cea60d16402c37ac4e","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2819","disease_name":"Spastic paraplegia-facial-cutaneous lesions syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000953","is_excluded":false,"label":"Hyperpigmentation of the skin","onset_id":null,"reference":"ORPHA:2819","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4d51b9d36cdbdb836513a080d306abc3820c476f06865714315b7fa2934c9e9d","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:2819","disease_name":"Spastic paraplegia-facial-cutaneous lesions syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001025","is_excluded":false,"label":"Urticaria","onset_id":null,"reference":"ORPHA:2819","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5078b060b642b3e0ad4cbf75af6b1677bf4a4c34894818e7de10c3b4cd765c68","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2819","disease_name":"Spastic paraplegia-facial-cutaneous lesions syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001347","is_excluded":false,"label":"Hyperreflexia","onset_id":null,"reference":"ORPHA:2819","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8543ad8cd479716c7fb8f5a503eaa983b54f627461b25fbd6c7b54c33d04d9d0","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2819","disease_name":"Spastic paraplegia-facial-cutaneous lesions syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001053","is_excluded":false,"label":"Hypopigmented skin patches","onset_id":null,"reference":"ORPHA:2819","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"afa9cbca958f890bcfa8a35ba072d9aeaeac88b5a846ab39af88747ac1df3da0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2819","disease_name":"Spastic paraplegia-facial-cutaneous lesions syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002353","is_excluded":false,"label":"EEG abnormality","onset_id":null,"reference":"ORPHA:2819","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c14bdd2577515fcbbf5ebf5db2753e7e947756b325f9d9b8af2d11eaf604fc77","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2819","disease_name":"Spastic paraplegia-facial-cutaneous lesions syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0010550","is_excluded":false,"label":"Paraplegia","onset_id":null,"reference":"ORPHA:2819","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fc0d0878e940ac212b6d9b8c27e82359e12b9bf92a03bcaad44f28aa8c1bde1f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2819","disease_name":"Spastic paraplegia-facial-cutaneous lesions syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"ORPHA:2819","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/806\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0017275\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0017275</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A complex form of hereditary spastic paraplegia characterized by delays in motor development followed by a slowly progressive spastic paraplegia (affecting mainly lower extremities) associated with a desquamating facial rash with butterfly distribution (presenting at around two months of age) and dysarthria. There have been no further descriptions in the literature since 1982.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/806\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"spastic-paraplegia-facial-cutaneous-lesions","sourceDocuments":[{"name":"GARD: Spastic paraplegia-facial-cutaneous lesions syndrome","reviewed":null,"source_release":"2026-10-25T03:38:22Z","url":"https://rarediseases.info.nih.gov/diseases/806"},{"name":"MONDO: spastic paraplegia-facial-cutaneous lesions syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0017275"}],"sourceNote":"","synonyms":["Bahemuka Brown syndrome","Bahemuka-Brown syndrome","spastic paraplegia facial cutaneous lesions"],"takeawayHtml":"","title":"spastic paraplegia-facial-cutaneous lesions syndrome"},"schemaVersion":1}
